Pharmacokinetics of pipamperone from three different tablet formulations.


Twenty-four (24) Caucasian male subjects completed a single-blind, randomised, three-treatment, three-period, cross-over study. In each treatment phase, subjects received a single dose of 144 mg pipamperone dihydrochloride (CAS 2448-68-2) (equivalent to 120 mg pipamperone; CAS 1893-33-0) as either the reference product (3 x 40 mg tablets), test product A (3… (More)


Cite this paper

@article{Potgieter2002PharmacokineticsOP, title={Pharmacokinetics of pipamperone from three different tablet formulations.}, author={Gerbrecht E Potgieter and Gerhard Groenewoud and Pierre J. Jordaan and Hans K L Hundt and Robert Schall and Michael Kummer and G{\"u}nter Sewarte-Ross}, journal={Arzneimittel-Forschung}, year={2002}, volume={52 6}, pages={430-4} }